These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 26428373)
1. The Latent Membrane Protein 1 (LMP1). Kieser A; Sterz KR Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. Kilger E; Kieser A; Baumann M; Hammerschmidt W EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091 [TBL] [Abstract][Full Text] [Related]
3. Unique signaling properties of CTAR1 in LMP1-mediated transformation. Mainou BA; Everly DN; Raab-Traub N J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074 [TBL] [Abstract][Full Text] [Related]
4. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways. Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival. Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277 [TBL] [Abstract][Full Text] [Related]
6. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation. Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250 [TBL] [Abstract][Full Text] [Related]
9. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104 [TBL] [Abstract][Full Text] [Related]
10. LMP1 structure and signal transduction. Eliopoulos AG; Young LS Semin Cancer Biol; 2001 Dec; 11(6):435-44. PubMed ID: 11669605 [TBL] [Abstract][Full Text] [Related]
11. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation. Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303 [TBL] [Abstract][Full Text] [Related]
13. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40. Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848 [TBL] [Abstract][Full Text] [Related]
14. Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1. Kieser A Biol Chem; 2008 Oct; 389(10):1261-71. PubMed ID: 18713013 [TBL] [Abstract][Full Text] [Related]
15. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin]. Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598 [TBL] [Abstract][Full Text] [Related]
17. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus. Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607 [TBL] [Abstract][Full Text] [Related]
18. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. Gires O; Kohlhuber F; Kilger E; Baumann M; Kieser A; Kaiser C; Zeidler R; Scheffer B; Ueffing M; Hammerschmidt W EMBO J; 1999 Jun; 18(11):3064-73. PubMed ID: 10357818 [TBL] [Abstract][Full Text] [Related]
19. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex. Fries KL; Miller WE; Raab-Traub N Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141 [TBL] [Abstract][Full Text] [Related]
20. NF-kappaB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells. Liljeholm S; Hughes K; Grundström T; Brodin P J Gen Virol; 1998 Sep; 79 ( Pt 9)():2117-25. PubMed ID: 9747720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]